For more information, contact:
Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study investigator Edy Kornelius, M.D., Ph.D., of Chung Shan Medical University in Taichung, Taiwan
[1] Its important to note that these uses are not FDA-approved
Starting Dose Schedules and Titration Timing Most semaglutide protocols begin with a 0.25 mg weekly dose, then increase every 4 weeks (so at weeks 1, 5, 9, and 13) until reaching your effective dose
Overview GHK-Cu is a research-grade copper-binding tripeptide supplied in lyophilized vial format for controlled laboratory use
When clinically appropriate, compounded formulations can also be less expensive than name-brand products, lowering out-of-pocket costs